Lipid Profile and Glycemic Control in Type 2 Diabetic Patients in Zawia, Libya: A Cross-Sectional Study
DOI:
https://doi.org/10.54361/LJMR.19.2.53Keywords:
Type 2 Diabetes Mellitus, Dyslipidemia, HbA1c, Cholesterol, Triglycerides, Cardiovascular Risk, Libya.Abstract
Background: Diabetes mellitus (DM) is a prevalent endocrine disorder commonly associated with dyslipidemia, a major cardiovascular risk factor. This study evaluated total cholesterol and triglyceride levels among patients with type 2 diabetes mellitus (T2DM) in Zawia city, Libya. Methods: A cross-sectional study was conducted at the Diabetes Center in Zawia city, including 100 adults (50 T2DM patients and 50 non-diabetic controls). Fasting blood sugar (FBS), HbA1c, total cholesterol, triglycerides, and uric acid were measured using standard assays. Statistical analyses included independent t-tests, one-way ANOVA, and Pearson correlation (p<0.05). Results: Compared with controls, T2DM patients had significantly lower total cholesterol (p=0.015), whereas triglycerides did not differ (p=0.47). FBS was markedly higher in the diabetes group (p<0.001). HbA1c showed a positive correlation with body weight (r=0.259, p=0.039) and was positively associated with age, with no significant sex difference. Conclusion: In this cohort, diabetic status was associated with lower total cholesterol but similar triglycerides compared with non-diabetic controls. Findings support prioritizing comprehensive risk reduction—glycemic optimization and weight management—while assessing lipid fractions beyond total cholesterol. Larger, multicenter studies with detailed lipoprotein profiling are recommended.
Downloads
References
1. Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107843.
2. American Diabetes Association. Standards of Medical Care in Diabetes-2024. Diabetes Care. 2024;47(Suppl 1):S1-S180.
3. Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111-88.
4. Toth PP, Philip S, Hull M, Granowitz C. Management of dyslipidemia in adults with diabetes mellitus: recent updates. Curr Cardiol Rep. 2021;23(9):120.
5. Elhadi M, Elhadi A, Bouhuwaish A, Bin Taher B, Alshiteewi FB, Elmabrouk A, et al. Prevalence of diabetes and metabolic syndrome in North Africa: a systematic review. BMC Public Health. 2021;21(1):1489.
6. Gana R, Elbarsha A, Saad M, Alhudiri I, Eltaweel W, Alzhrani K, et al. Diabetes care challenges in Libya: current status and future needs. Libyan J Med. 2023;18(1):2256432.
7. Feingold KR, Grunfeld C. Dyslipidemia in Diabetes. In: Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK305900/.
8. International Diabetes Federation. IDF Diabetes Atlas, 10th edition. Brussels, Belgium: International Diabetes Federation; 2025.
9. Alshkri MM, Elmehdawi RR. Metabolic syndrome among type-2 diabetic patients in Benghazi-Libya: a pilot study. Libyan J Med. 2008;3(4):177-80.
10. Thwer H, Ali K, Agena M, Said M. Prevalence of Iron Deficiency Anemia and Serum Magnesium Among Pregnant Women in Zawia City. LJMR [Internet]. 2025 Jan. 1 [cited 2025 Nov. 2];19(1):228-41. Available from: https://ljmr.ly/index.php/ljmr/article/view/368
11. Joseph JJ, Deedwania P, Acharya T, Aguilar D, Bhatt DL, Chyun DA, et al. Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association. Circulation. 2022;146(15):e722-e39.
12. Ginsberg HN, Wang C. The Here, Now and then of Hypertriglyceridemia and Cardiovascular Disease. J Clin Endocrinol Metab. 2021;106(8):e3117-e28.
13. Siddiqui K, George TP, Joy SS, Alfadda AA. Risk factors of chronic kidney disease among type 2 diabetic patients with longer duration of diabetes. Front Endocrinol (Lausanne). 2022 Dec 9;13:1079725. doi: 10.3389/fendo.2022.1079725. PMID: 36568108; PMCID: PMC9780388.
14. Said M, Agena M. Prevalence of anemia in dialysis patients in Northwestern of Libya. LJMR [Internet]. 2025 May 13 [cited 2025 Oct. 26];16(2-B):129-43. Available from: https://ljmr.ly/index.php/ljmr/article/view/354
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Abdalrauf Al-Fourti, Khayri A. Ali, Mahmoud B. Agena, Almabrok D. Saeed, Mohamed T. Saad, Mohamed D. Said (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Open Access Policy
Libyan journal of medical Research (LJMR).is an open journal, therefore there are no fees required for downloading any publication from the journal website by authors, readers, and institution.
The journal applies the license of CC BY (a Creative Commons Attribution 4.0 International license). This license allows authors to keep ownership f the copyright of their papers. But this license permits any user to download , print out, extract, reuse, archive, and distribute the article, so long as appropriate credit is given to the authors and the source of the work.
The license ensures that the article will be available as widely as possible and that the article can be included in any scientific archive.
Editorial Policy
The publication of an article in a peer reviewed journal is an essential model for Libyan journal of medical Research (LJMR). It is necessary to agree upon standards of expected ethical behavior for all parties involved in the act of publishing: the author, the journal editorial, the peer reviewer and the publisher.
Any manuscript or substantial parts of it, submitted to the journal must not be under consideration by any other journal. In general, the manuscript should not have already been published in any journal or other citable form, although it may have been deposited on a preprint server. Authors are required to ensure that no material submitted as part of a manuscript infringes existing copyrights, or the rights of a third party.
Authorship Policy
The manuscript authorship should be limited to those who have made a significant contribution and intellectual input to the research submitted to the journal, including design, performance, interpretation of the reported study, and writing the manuscript. All those who have made significant contributions should be listed as co-authors.
Others who have participated in certain substantive aspects of the manuscript but without intellectual input should only be recognized in the acknowledgements section of the manuscript. Also, one of the authors should be selected as the corresponding author to communicate with the journal and approve the final version of the manuscript for publication in the LJMR.
Peer-review Policy
- All the manuscripts submitted to LJMR will be subjected to the double-blinded peer-review process;
- The manuscript will be reviewed by two suitable experts in the respective subject area.
- Reports of all the reviewers will be considered while deciding on acceptance/revision or rejection of a manuscript.
- Editor-In-Chief will make the final decision, based on the reviewer’s comments.
- Editor-In-Chief can ask one or more advisory board members for their suggestions upon a manuscript, before making the final decision.
- Associate editor and review editors provide administrative support to maintain the integrity of the peer-review process.
- In case, authors challenge the editor’s negative decision with suitable arguments, the manuscript can be sent to one more reviewer and the final decision will be made based upon his recommendations.
